- Saturday June 17, 1045-1215 Cornea and refractive showdown
- Saturday June 17, 1330-1500 New strategies for old corneal issues
- Saturday June 17, 1545-1715 Things that make you go hmm: Latest options in refractive corneal surgery
- Sunday June 18, 1330-1500 Exploring the frontiers of component surgery of the cornea
- Sunday June 18, 1545-1715 Making the ocular surface great again
Canadian Cornea, External Disease & Refractive Surgery Society
Cornea and refractive showdown
Saturday June 17, 1045—1215
Room 518AB
Learning objectives
At the end of this session, participants will be able to:
- List advantages and disadvantages of the various types of corneal transplants
- List advantages and disadvantages of certain types of corneal-based refractive procedures
- Describe current trends in refractive cataract surgery
GUEST SPEAKERSDamien Gatinel, MD MODERATORPaul Dubord, MD |
PanelistsRon Baldassare, MD FACULTYHall F. Chew, MD |
Agenda
| 1045 | Introduction |
| 1047 | Keratoplasty for ectasia and anterior corneal pathology: PKP is better • Mahshad Darvish-Zargar |
| 1052 | Keratoplasty for ectasia and anterior corneal pathology: DALK is better • Hall F. Chew |
| 1057 | Discussion |
| 1100 | Crosslinking for ectasia: Epithelium-on is better • Joshua Teichman |
| 1105 | Crosslinking for ectasia: Epithelium-off is better • Setareh Ziai, Rusty Ritenour |
| 1110 | Discussion |
| 1113 | Keratoplasty for endothelial dysfunction: DSAEK is better • Neera Singal |
| 1118 | Keratoplasty for endothelial dysfunction: DMEK is better • Michele Mabon |
| 1123 | Discussion |
| 1126 | Laser vision correction for myopia: LASIK is better • Damien Gatinel |
| 1131 | Laser vision correction for myopia: SMILE is better • Jodhbir S. Mehta |
| 1136 | Discussion |
| 1139 | IOL calculations in eyes with corneal conditions • Guillermo Rocha |
| 1149 | Comparison of femtolasers • Jodhbir S. Mehta |
| 1159 | Trifocal vs bifocal vs EDOF IOLs • Damien Gatinel |
| 1209 | Discussion |
| 1215 | Closing remarks |
New strategies for old corneal issues
Saturday June 17, 1330—1500
Room 518AB
Learning objectives
At the end of this session, participants will be able to:
- Describe treatments available for anesthetic, vascularized, infected, non-healing corneas
- List criteria for progression of keratoconus
GUEST SPEAKERSMODERATORAllan Slomovic, MD |
PanelistsJit Gohill, MD FACULTYJohanna Choremis, MD |
Agenda
| 1330 | Introduction |
| 1332 | HOT TOPIC Corneal neurotisation reinnervates anaesthetic corneas and improves ocular surface health • Asim Ali, Simon Fung, Joseph Catapano, William Halliday, Emily Ho, Ronald Zuker, Gregory Borschel |
| 1337 | A novel amniotic membrane-conformer assembly for acute Stevens-Johnson syndrome/toxic epidermal necrolysis • Simon S. M. Fung, Michael Webb, Crystal Cheung, Hall F. Chew, Kamiar Mireskandari, Asim Ali |
| 1342 | The EyePrintPRO therapeutic scleral contact lens: Indications and outcomes • Michael T. B. Nguyen, Vishakha Thakrar, Clara C. Chan |
| 1347 | Discussion |
| 1352 | The value of corneoscleral rim cultures in keratoplasty: A systematic review and cost-effectiveness analysis • Efstathia Kiatos, William Hodge, James J. Armstrong, Stephen Tsioros, Monali Malvankar, Cindy Hutnik |
| 1357 | Feasibility of implementing a national corneal transplant registry: 2016 update on the Ottawa pilot study • Reginald Robert G. Tan, Yufeng Chen, Mohammed Taha, Pablo Morales, Harrish Nithianandan, George Mintsioulis, Setareh Ziai, Kashif Baig |
| 1402 | Vitritis after Boston keratoprosthesis type 1 implantation • Davin Johnson, Marie-Claude Robert, Soumaya Bouhout, Mona Harissi-Dagher |
| 1407 | Discussion |
| 1412 | Bruce Jackson Lecture: Redefining the criteria for keratoconus progression • Damien Gatinel |
| 1422 | Discussion |
| 1425 | Influence of pupil dynamics for treatment centration • Damien Gatinel |
| 1435 | Discussion |
| 1438 | Handling corneal neovascularization in 2017 • Johanna Choremis |
| 1444 | CXL for corneal infections • Marie-Ève Légaré |
| 1450 | Update on amniotic membrane options for the ocular surface • Louis Racine |
| 1456 | Discussion |
| 1500 | Closing remarks |
Things that make you go hmm: Latest options in refractive corneal surgery
Saturday June 17, 1545—1715
Room 518AB
Learning objectives
At the end of this session, participants will be able to:
- Describe procedures performed to improve vision in ectasia
- Assess developments in corneal-based laser vision correction
GUEST SPEAKERSDamien Gatinel, MD MODERATORMona Harissi-Dagher, MD |
PanelistsMark Fava, MD |
Agenda
| 1545 | Introduction |
| 1547 | Phototherapeutic keratectomy: A review of indications and outcomes using a novel refractively neutral technique • Michael T. B. Nguyen, Armand Borovik, Nir Sorkin, David Rootman, Clara C. Chan |
| 1552 | Higher order aberration (HOA) guided phototherapeutic keratectomy (PTK) and collagen crosslinking (CXL) in the treatment of keratoconus • Victor Penner, Kylee Lewis, Guillermo Rocha |
| 1557 | Outcomes of small-incision lenticule extraction (SMILE) in myopia • Mohammad Hamid, Michel Podtetenev |
| 1602 | Discussion |
| 1607 | Update on corneal inlay options for presybopia correction • Damien Gatinel |
| 1617 | Update on laser refractive surgery options for presybopia correction • Jodhbir S. Mehta |
| 1627 | Discussion |
| 1632 | HOT TOPIC A head to head comparison of CXL alone vs CXL+ICR vs CXL+TG-PRK in patients with progressive keratoconus, PMD, and LASIK-induced corneal ectasia: A prospective single center trial • Neera Singal, Stephan Ong Tone, Raymond Stein, Matthew Bujak, Clara C. Chan, Hall F. Chew, Sherif El-Defrawy, Yaping Jin, Theodore Rabinovitch, David Rootman, Allan Slomovic, Wendy Hatch |
| 1637 | Ron Jans Award | 2nd prize, COS Awards of Excellence: Corneal collagen cross-linking in the management of keratoconus in Canada: A cost-effectiveness analysis • Victoria C. Leung, Petros Pechlivanoglou, Hall F. Chew, Wendy Hatch |
| 1642 | Visual, refractive, and tomographic outcomes of adolescents following corneal collagen cross-linking for keratoconus • Esteban Santiago, Vinay Kansal, Yelin Yang, Kashif Baig |
| 1647 | Discussion |
| 1652 | Rainbow glare after FemtoLasik: Cause, mechanism, and correction • Damien Gatinel |
| 1702 | The science behind SMILE • Jodhbir S. Mehta |
| 1712 | Discussion |
| 1715 | Closing remarks |
Exploring the frontiers of component surgery of the cornea
Sunday June 18, 1330—1500
Room 519AB
Learning objectives
At the end of this session, participants will be able to:
- Integrate developments in DMEK surgery
- Describe techniques for DALK surgery
GUEST SPEAKERJodhbir S. Mehta, BSc (Hons.), MBBS, FRCOphth, FRSC (Ed) MODERATORRookaya Mather, MD |
PanelistsMazen Choulakian, MD FACULTYKashif Baig, MD |
Agenda
| 1330 | Introduction |
| 1332 | DMEK surgery: A simple way to forego peripheral iridotomy • Julia Talajic, Mathieu Mercier, Michele Mabon, Isabelle Brunette, Johanna Choremis |
| 1337 | HOT TOPIC Descemetorhexis alone or with ripasudil salvage for Fuchs’ endothelial dystrophy • Greg Moloney, C. Petsoglou, M. Ball, Y. Kerdraon, R. Hollhumer, N. Spiteri, Simon P. Holland |
| 1342 | Aberrations induced by Descemet membrane endothelial keratoplasty (DMEK) • Mohammed Taha, Reginald G. Tan, Pablo Morales, Kashif Baig |
| 1347 | Discussion |
| 1352 | Comparison of punching techniques for preparation of endothelial grafts for Descemet membrane endothelial keratoplasty • Reginald Robert G. Tan, Mohammed Taha, Pablo Morales, Esteban Santiago, Nima Noordeh, Yelin Yang, Kashif Baig |
| 1357 | Preliminary outcome of hemi-Descemet membrane endothelial keratoplasty (DMEK) and quarter-DMEK for Fuchs endothelial dystrophy • C. Maya Tong, Nadine Gerber-Hollbach, Lamis Baydoun, Thomas M. Muller, Jessica T. Lie, Isabel Dapena, Gerrit R. J. Melles |
| 1402 | Outcomes at one-year follow up of hemi-Descemet membrane endothelial keratoplasty • Javiera Compan, Yelin Yang, Pablo Morales, Esteban Santiago, Kashif Baig |
| 1407 | Discussion |
| 1412 | DALK: Latest developments • Jodhbir S. Mehta |
| 1422 | DALK: My technique • Julia Talajic |
| 1432 | Discussion |
| 1437 | DMEK: Transitioning from DSAEK • Jodhbir S. Mehta |
| 1447 | DMEK: My technique • Kashif Baig |
| 1457 | Discussion |
| 1500 | Closing remarks |
Making the ocular surface great again
Sunday June 18, 1545—1715
Room 519AB
Learning objectives
At the end of this session, participants will be able to:
- Describe new trends in managing dry eye disease
- Assess imaging and technologies used for the ocular surface
GUEST SPEAKERSDamien Gatinel, MD MODERATORStephen Brodovsky, MD |
PanelistsAshley Brissette, MD FACULTYAhmed Al-Ghoul, MD |
Agenda
| 1545 | Introduction |
| 1546 | What am I missing? The case I lost sleep over! • Bruce Jackson |
| 1552 | Discussion |
| 1555 | HER2 as a possible therapeutic target in squamous cell carcinoma of the conjunctiva • Evangelina Esposito, Pablo Zoroquiain, Ana B. Toledo Dias, Miguel Burnier |
| 1600 | The corneal endothelium in pediatric posterior polymorphous corneal dystrophy: A specular microscopic study • Hamza Sami, Ali El Hamouly, Simon S. M. Fung, Dishay Jiandani, Kamiar Mireskandari, Asim Ali |
| 1605 | Nitric oxide, administered using copper-chitosan derivatives, accelerates corneal epithelial wound healing • Vasiliki Tellios, Hong Liu, Nikoleta Tellios, Kathleen Fontana, Bulent Mutus, Cindy Hutnik |
| 1610 | Discussion |
| 1613 | Ikervis, Restasis, and Xiidra: What you need to know • Setareh Ziai |
| 1622 | Overview of devices to treat meibomian gland dysfunction • Ahmed Al-Ghoul |
| 1631 | Discussion |
| 1636 | Effect of the epithelial layer on corneal topography • Damien Gatinel |
| 1645 | Femto-pterygium surgery • Jodhbir S. Mehta |
| 1654 | Discussion |
| 1658 | Agreement and reliability of aberrometry measurements in normal eyes using iDesign, iTrace and Pentacam • Pablo Morales, Antoine Goulet, Reginald Robert G. Tan, Mohammed Taha, Kashif Baig |
| 1703 | Financial burden of dry eye disease and impact on patient adherence: A case study of Restasis following conclusion of Health Canada’s Special Access Program • Rami A. Abo-Shasha |
| 1708 | HOT TOPIC Overview of clinical efficacy and safety of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease • Mahshad Darvish-Zargar, Edward J. Holland, Clara C. Chan, Kelly K. Nichols, Joseph Tauber, Christophe Baudouin, Aparna Raychaudhuri, Monica Roy, Amir Shojaei |
| 1713 | Discussion |
| 1715 | Closing remarks |
Damien Gatinel, MD
Jodhbir S. Mehta, BSc (Hons.), MBBS, FRCOphth, FRSC (Ed)